InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 07/31/2006

Re: MXAMDUD post# 202929

Wednesday, 11/08/2017 8:30:56 AM

Wednesday, November 08, 2017 8:30:56 AM

Post# of 403047
NO! Short term share price of a pre-revenue clinical stage biotech company is not a measure of the market's view of management! It simply is not.

And then you throw in all manner of unsupported and ridicules charges such as "toxic", "misleading", "too large salaries", "delay", "broken promise". THAT IS ALL NONSENSE! IT'S MADE UP NONSENSE!

Unsupported, contrived, Reflexive Negativism is not going to be the winner here. To the contrary, the patient, actual, long term shareholder WILL be the winner.

Just wait...

DOTB
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News